The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

A nebulizer is a machine that turns liquid medication into an inhalable mist and is used for people with respiratory conditions.

The Breathing Association, a Columbus-based nonprofit that helps 15,000 people with utility costs, faces closure due to the ...

Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...

The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...

About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the ...

Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe At-home Respiratory Care Services Market Size, Share & Trends Analysis Report by Therapy (Oxygen Therapy, Non-Invasive Ventilation), by Indication ...

(MENAFN- GlobeNewsWire - Nasdaq) Significant market opportunities in the Europe at-home respiratory care services sector include growing demand driven by technological advancements like smart inhalers ...

As cooler temperatures and shifting air quality arrive, many families notice changes in their breathing. Dry air, allergens, ...

A peak flow meter is a handheld device that measures airflow rate and can help those with respiratory conditions like asthma monitor their condition.

MannKind remains a Buy, driven by Tyvaso DPI's strong market position and Technosphere platform optionality. Learn more about ...

Roger Jeffs, Chief Executive Officer of Liquidia, said: ”Our first R&D Day represents an important milestone as we bring together our team with recognized experts in the fields of PAH and PH-ILD to ...